Efficacy of Recombinant Human Endostatin plus Neoadjuvant Chemotherapy for Osteosarcoma and Its Influence on Serum VEGF and MMP-9 Levels

OBJECTIVE: To investigate the efficacy of recombinant human endostatin (rh-Endo) plus neoadjuvant chemotherapy (NACT) for osteosarcoma (OSA) and its influence on serum vascular endothelial growth factor (VEGF) and matrix metalloproteinase-9 (MMP-9). METHODS: The case data of 141 OSA patients present...

Descripción completa

Detalles Bibliográficos
Autores principales: Sui, Wei, Lin, Guanghui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9985508/
https://www.ncbi.nlm.nih.gov/pubmed/36880008
http://dx.doi.org/10.1155/2023/8161683

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9985508/
https://www.ncbi.nlm.nih.gov/pubmed/36880008
http://dx.doi.org/10.1155/2023/8161683

Ejemplares similares